All Type of News
Korean drug firm signs record license deal
Korean biopharmaceutical company Medytox said Thursday that it has signed a deal to exclusively license a neurotoxin to Procter & Gamble Pharmaceuticals (P&GP) that could be worth US$$362 million.
Under the deal, A...
Drugmakers to scale back pharmacy business
A growing number of pharmaceutical firms are seeking to curtail their direct transactions with pharmacies in a bid to boost their faltering earnings.
The main reason drug firms has opted for such tactics lies in th...
MBC issues correction over Ursa
The broadcaster MBC on Wednesday issued the correction over Daewoong Pharm’s Ursa, thehe best-selling hepatic function medicine, denying that Ursa is nearly similar to a digestive, not a drug to combat fatigue, which ...
Bioequivalence-approved drugs top 6,410 in September
The number of bioequivalence drugs and their reference drugs, which was approved by the Ministry of Food and Drug Safety, came to 6,410 in September, up 224 compared to 6,145 in April, a government data showed Wednesd...
Measures on hospitals’ ambiguous accounting to be toughened
The Ministry of Health and Welfare said it will put into practice measures to keep state-run medical centers from fabricating their profits by calculating the national subsidies as capital, not depreciation cost.
“...
Ildong to distribute Smiths Medical’s medical devices in Korea
Ildong Pharmaceutical and Smiths Medical, a leading global medical device manufacturer, has signed a distribution agreement for the exclusive sale of Smiths Medical’s main medical devices in Korea, such as Jelco Intui...
Mundipharma CEO promoted to general managerMundipharma International on Sept. 17 said it promoted Mundipharm Korea president Lee Jong-ho to general manager in seven Southeast countries as well as Korea.
The promotion,...
|
KMA files petition to court
The Korea Medical Association (KMA) said Tuesday it submitted a petition to the Seoul Central District Court to deal prudently with two doctors who allegedly took kickbacks from Dong-A Pharmaceutical in exchange for t...
Drug regulator to appeal Wales Korea case
The Ministry of Food and Drug Safety (MFDS) said Tuesday it will file an appeal immediately with the Higher Court against the Suwon District Court’s ruling in favor of Wales Korea to lift the sales ban of some medicin...
Drug watchdog suspends production of Dongwha’s anti-diarrheal medicationsKorea‘s drug watchdog said Tuesday that it has imposed a ban on the production of Dong-A Pharmaceutical’s anti-diarrheal medication Lacterol, which has been in three different d...
|
